Here, using an Fbxl6 knock-in mouse model and HCC patient tissues, we demonstrate the crucial roles of FBXL6 in liver cancer development and show by example that blocking TKT would be sufficient to impede HCC development in a subset of HCC patients with high FBXL6 expression. This evidence concerns the gene FBXL6 and hepatocellular carcinoma.